Topics

"Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." Drugs and Medication Database

18:55 EST 26th January 2020 | BioPortfolio

Here are the most relevant "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." Drugs and Medications that we have found in our database.

More Information about "Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS." on BioPortfolio

We have published hundreds of Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS. news stories on BioPortfolio along with dozens of Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS. Clinical Trials and PubMed Articles about Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS. Companies in our database. You can also find out about relevant Trial to Evaluate the Safety and Efficacy of MB-102 in Patients With BPDCN, AML, and hrMDS. Drugs and Medications on this site too.

Showing "Trial Evaluate Safety Efficacy Patients With BPDCN hrMDS" Drugs and Medications, all 1

Probably Relevant

Elzonris [stemline therapeutics, inc.]

These highlights do not include all the information needed to use ELZONRIS™ safely and effectively. See full prescribing information for ELZONRIS. ELZONRIS (tagraxofusp-erzs) injection, for intravenous use Initial U.S. Approval: 2018



Quick Search